These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Basic principles of hormone replacement therapy in the postmenopause]. Dören M Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374 [TBL] [Abstract][Full Text] [Related]
7. [New evidence of conjugated estrogen and 17beta-estradiol for treatment and prevention of osteoporosis]. Kurabayashi T Nihon Rinsho; 2007 Nov; 65 Suppl 9():369-73. PubMed ID: 18161134 [No Abstract] [Full Text] [Related]
8. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women. Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M Menopause; 2006; 13(4):651-9. PubMed ID: 16837887 [TBL] [Abstract][Full Text] [Related]
9. [Effect and tolerability of sequential administration of estradiol valerate and medroxyprogesterone acetate on menopausal symptoms, hormonal profile and biochemical markers in climacteric women]. Radowicki S; Skórzewska K; Borakowska B; Wierzba W; Michalewski K Ginekol Pol; 2004 Jan; 75(1):39-46. PubMed ID: 15112472 [TBL] [Abstract][Full Text] [Related]
10. What you need to know: prescribing hormone replacement therapy. McCarthy TG Singapore Med J; 1997 Apr; 38(4):179-80. PubMed ID: 9269401 [No Abstract] [Full Text] [Related]
11. [Treatment of osteoporosis by the gynecologist]. Schneider HP; Dören M Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982 [TBL] [Abstract][Full Text] [Related]
12. [Estrogens and gestagens in the prevention of osteoporosis]. Lauritzen C Zentralbl Gynakol; 1991; 113(8):475-8. PubMed ID: 1651636 [No Abstract] [Full Text] [Related]
13. Hormone replacement therapy: optimising the dose and route of administration. Montgomery Rice V Drugs Aging; 2002; 19(11):807-18. PubMed ID: 12428992 [TBL] [Abstract][Full Text] [Related]
14. Optimizing the dose of hormone replacement therapy. Rice VM Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707 [TBL] [Abstract][Full Text] [Related]
15. Is 1 mg of estradiol valerate or 0.625 mg of conjugated estrogens sufficient for all women to prevent menopausal bone loss? Duursma SA; de Raadt M; Raymakers JA; Haspels AA Gynecol Endocrinol; 1992 Sep; 6(3):205-9. PubMed ID: 1332428 [TBL] [Abstract][Full Text] [Related]
16. Morning and evening administration of hormone therapy in perimenopausal women. Pongsatha S; Chainual A; Morakote N Int J Gynaecol Obstet; 2005 Oct; 91(1):77-8. PubMed ID: 16122753 [No Abstract] [Full Text] [Related]
17. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT. Brown S Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171 [No Abstract] [Full Text] [Related]